{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:44:24Z","timestamp":1787013864796,"version":"build-2736575974"},"reference-count":28,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T00:00:00Z","timestamp":1551052800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81741058"],"award-info":[{"award-number":["81741058"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81460163"],"award-info":[{"award-number":["81460163"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81300786"],"award-info":[{"award-number":["81300786"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002412","name":"Xi\u2019an Jiaotong University","doi-asserted-by":"publisher","award":["XJTU1AF\u2010CRF\u20102016\u2010014"],"award-info":[{"award-number":["XJTU1AF\u2010CRF\u20102016\u2010014"]}],"id":[{"id":"10.13039\/501100002412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Ophthalmologica"],"published-print":{"date-parts":[[2019,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>\n                      To investigate the semophorin 3A (\n                      <jats:styled-content style=\"fixed-case\">SEMA<\/jats:styled-content>\n                      3A) level in aqueous humor of patients with retinal vein occlusion (\n                      <jats:styled-content style=\"fixed-case\">RVO<\/jats:styled-content>\n                      ) and explore the correlation of\n                      <jats:styled-content style=\"fixed-case\">SEMA<\/jats:styled-content>\n                      3A with macular oedema and ganglion cell degeneration in\n                      <jats:styled-content style=\"fixed-case\">RVO<\/jats:styled-content>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This comparative study prospectively included 41 consecutive patients (41 eyes) with\n                      <jats:styled-content style=\"fixed-case\">RVO<\/jats:styled-content>\n                      who had intravitreal anti\u2010\n                      <jats:styled-content style=\"fixed-case\">VEGF<\/jats:styled-content>\n                      injections from March 2014 to March 2015 for cystoid macular oedema (\n                      <jats:styled-content style=\"fixed-case\">CME<\/jats:styled-content>\n                      ) or neovascular glaucoma (\n                      <jats:styled-content style=\"fixed-case\">NVG<\/jats:styled-content>\n                      ). The patients were divided into three groups according to the fluorescein angiograghy (\n                      <jats:styled-content style=\"fixed-case\">FFA<\/jats:styled-content>\n                      ): central retinal vein occlusion (\n                      <jats:styled-content style=\"fixed-case\">CRVO<\/jats:styled-content>\n                      ) group (\n                      <jats:italic>n\u00a0<\/jats:italic>\n                      =\n                      <jats:italic>\u00a0<\/jats:italic>\n                      15), branch retinal vein occlusion (\n                      <jats:styled-content style=\"fixed-case\">BRVO<\/jats:styled-content>\n                      ) group (\n                      <jats:italic>n\u00a0<\/jats:italic>\n                      =\n                      <jats:italic>\u00a0<\/jats:italic>\n                      15) and\n                      <jats:styled-content style=\"fixed-case\">NVG<\/jats:styled-content>\n                      group (secondary to\n                      <jats:styled-content style=\"fixed-case\">CRVO<\/jats:styled-content>\n                      ,\n                      <jats:italic>n\u00a0<\/jats:italic>\n                      =\n                      <jats:italic>\u00a0<\/jats:italic>\n                      11). The patients who had undergone cataract surgery (\n                      <jats:italic>n\u00a0<\/jats:italic>\n                      =\n                      <jats:italic>\u00a0<\/jats:italic>\n                      16) during the same period served as controls. The\n                      <jats:styled-content style=\"fixed-case\">SEMA<\/jats:styled-content>\n                      3A concentration in aqueous humor collected before the initial anti\u2010\n                      <jats:styled-content style=\"fixed-case\">VEGF<\/jats:styled-content>\n                      injection was determined by enzyme\u2010linked immunosorbent assay (\n                      <jats:styled-content style=\"fixed-case\">ELISA<\/jats:styled-content>\n                      ). Central retinal thickness (\n                      <jats:styled-content style=\"fixed-case\">CRT<\/jats:styled-content>\n                      ), cube volume (\n                      <jats:styled-content style=\"fixed-case\">CV<\/jats:styled-content>\n                      ) and ganglion cell\u2010inner plexiform layer (\n                      <jats:styled-content style=\"fixed-case\">GC<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">IPL<\/jats:styled-content>\n                      ) thickness was analysed by spectral\u2010domain optical coherence tomography (\n                      <jats:styled-content style=\"fixed-case\">SD<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">OCT<\/jats:styled-content>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Semaphorin 3A level in\n                      <jats:styled-content style=\"fixed-case\">CRVO<\/jats:styled-content>\n                      group (1.52\u00a0\u00b1\u00a01.23\u00a0ng\/ml) and\n                      <jats:styled-content style=\"fixed-case\">NVG<\/jats:styled-content>\n                      group (1.67\u00a0\u00b1\u00a00.98\u00a0ng\/ml) were significantly higher than the control group (0.66 \u00b1 0.58\u00a0ng\/ml; both p\n                      <jats:italic>\u00a0<\/jats:italic>\n                      &lt;\n                      <jats:italic>\u00a0<\/jats:italic>\n                      0.05). Moreover,\n                      <jats:styled-content style=\"fixed-case\">SEMA<\/jats:styled-content>\n                      3A level in\n                      <jats:styled-content style=\"fixed-case\">CRVO<\/jats:styled-content>\n                      group was higher than\n                      <jats:styled-content style=\"fixed-case\">BRVO<\/jats:styled-content>\n                      group (1.52\u00a0\u00b1\u00a01.23\u00a0ng\/ml versus 0.53\u00a0\u00b1\u00a00.37\u00a0ng\/ml; p\n                      <jats:italic>\u00a0<\/jats:italic>\n                      &lt;\n                      <jats:italic>\u00a0<\/jats:italic>\n                      0.05).\n                      <jats:styled-content style=\"fixed-case\">SEMA<\/jats:styled-content>\n                      3A level was positively correlated with\n                      <jats:styled-content style=\"fixed-case\">CRT<\/jats:styled-content>\n                      and\n                      <jats:styled-content style=\"fixed-case\">CV<\/jats:styled-content>\n                      in both\n                      <jats:styled-content style=\"fixed-case\">BRVO<\/jats:styled-content>\n                      group (\n                      <jats:styled-content style=\"fixed-case\">CRT<\/jats:styled-content>\n                      <jats:italic>r\u00a0<\/jats:italic>\n                      =\n                      <jats:italic>\u00a0<\/jats:italic>\n                      0.6535, p\n                      <jats:italic>\u00a0<\/jats:italic>\n                      =\n                      <jats:italic>\u00a0<\/jats:italic>\n                      0.0082;\n                      <jats:styled-content style=\"fixed-case\">CV<\/jats:styled-content>\n                      <jats:italic>r\u00a0<\/jats:italic>\n                      =\n                      <jats:italic>\u00a0<\/jats:italic>\n                      0.5190, p\n                      <jats:italic>\u00a0<\/jats:italic>\n                      =\n                      <jats:italic>\u00a0<\/jats:italic>\n                      0.0474) and\n                      <jats:styled-content style=\"fixed-case\">CRVO<\/jats:styled-content>\n                      group (\n                      <jats:styled-content style=\"fixed-case\">CRT<\/jats:styled-content>\n                      <jats:italic>r\u00a0<\/jats:italic>\n                      =\n                      <jats:italic>\u00a0<\/jats:italic>\n                      0.6270, p\n                      <jats:italic>\u00a0<\/jats:italic>\n                      =\n                      <jats:italic>\u00a0<\/jats:italic>\n                      0.0124;\n                      <jats:styled-content style=\"fixed-case\">CV<\/jats:styled-content>\n                      <jats:italic>r\u00a0<\/jats:italic>\n                      =\n                      <jats:italic>\u00a0<\/jats:italic>\n                      0.6898, p\n                      <jats:italic>\u00a0<\/jats:italic>\n                      =\n                      <jats:italic>\u00a0<\/jats:italic>\n                      0.0044). In\n                      <jats:styled-content style=\"fixed-case\">RVO<\/jats:styled-content>\n                      patients, the\n                      <jats:styled-content style=\"fixed-case\">GC<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">IPL<\/jats:styled-content>\n                      thickness of affected eyes were significantly reduced compared with the normal follow eyes (\n                      <jats:styled-content style=\"fixed-case\">CRVO<\/jats:styled-content>\n                      <jats:italic>t\u00a0<\/jats:italic>\n                      =\n                      <jats:italic>\u00a0<\/jats:italic>\n                      4.55, p\n                      <jats:italic>\u00a0<\/jats:italic>\n                      =\n                      <jats:italic>\u00a0<\/jats:italic>\n                      0.006;\n                      <jats:styled-content style=\"fixed-case\">BRVO<\/jats:styled-content>\n                      <jats:italic>t\u00a0<\/jats:italic>\n                      =\n                      <jats:italic>\u00a0<\/jats:italic>\n                      4.54, p\n                      <jats:italic>\u00a0<\/jats:italic>\n                      =\n                      <jats:italic>\u00a0<\/jats:italic>\n                      0.004). Meanwhile, negative correlation of\n                      <jats:styled-content style=\"fixed-case\">SEMA<\/jats:styled-content>\n                      3A level with\n                      <jats:styled-content style=\"fixed-case\">GC<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">IPL<\/jats:styled-content>\n                      thickness was found in both\n                      <jats:styled-content style=\"fixed-case\">BRVO<\/jats:styled-content>\n                      group (\n                      <jats:italic>r\u00a0<\/jats:italic>\n                      =\n                      <jats:italic>\u00a0<\/jats:italic>\n                      \u22120.5906, p\n                      <jats:italic>\u00a0<\/jats:italic>\n                      =\n                      <jats:italic>\u00a0<\/jats:italic>\n                      0.0205) and\n                      <jats:styled-content style=\"fixed-case\">CRVO<\/jats:styled-content>\n                      group (\n                      <jats:italic>r\u00a0<\/jats:italic>\n                      =\n                      <jats:italic>\u00a0<\/jats:italic>\n                      \u22120.6100, p\n                      <jats:italic>\u00a0<\/jats:italic>\n                      =\n                      <jats:italic>\u00a0<\/jats:italic>\n                      0.0157).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Semaphorin 3A level is increased in aqueous humor of\n                      <jats:styled-content style=\"fixed-case\">RVO<\/jats:styled-content>\n                      patients. Positive correlation of\n                      <jats:styled-content style=\"fixed-case\">CRT<\/jats:styled-content>\n                      as well as negative correlation of\n                      <jats:styled-content style=\"fixed-case\">GC<\/jats:styled-content>\n                      \u2010\n                      <jats:styled-content style=\"fixed-case\">IPL<\/jats:styled-content>\n                      thickness with\n                      <jats:styled-content style=\"fixed-case\">SEMA<\/jats:styled-content>\n                      3A may suggest a pathological role of\n                      <jats:styled-content style=\"fixed-case\">SEMA<\/jats:styled-content>\n                      3A in macular oedema and ganglion cell degeneration during\n                      <jats:styled-content style=\"fixed-case\">RVO<\/jats:styled-content>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/aos.14079","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T01:17:17Z","timestamp":1551143837000},"page":"273-278","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Aqueous semaphorin 3A level correlates with retinal macular oedema and ganglion cell degeneration in patients with retinal vein occlusion"],"prefix":"10.1111","volume":"97","author":[{"given":"Shengxiang","family":"Guo","sequence":"first","affiliation":[{"name":"Department of Ophthalmology First Affiliated Hospital of Xi'an Jiaotong University Xi'an China"},{"name":"Department of Ophthalmology Xi'an Third Hospital Xi'an China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology First Affiliated Hospital of Xi'an Jiaotong University Xi'an China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengli","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Xi'an Third Hospital Xi'an China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology First Affiliated Hospital of Xi'an Jiaotong University Xi'an China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2300-8614","authenticated-orcid":false,"given":"Jingming","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology First Affiliated Hospital of Xi'an Jiaotong University Xi'an China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,2,25]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2015-308106"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0155319"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2003.12.007"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.11.011"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1159\/000320009"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.2174\/1573399811666150615151324"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2013.09.003"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI76492"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2006.06.052"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068149"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1159\/000431196"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep07890"},{"key":"e_1_2_5_14_1","first-page":"440","article-title":"[The effect of semaphorin 3A in the process of apoptosis in oxygen induced retinopathy in rats]","volume":"50","author":"Hua N","year":"2014","journal-title":"Chin J Ophthalmol"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-10-311589"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.13-13587"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.16-19468"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.15-17678"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2017.08.005"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1996.01100140443012"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/112067211002000222"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1242\/dev.127670"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2007.118497"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2017-311614"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.07.017"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-008-8518-z"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.13-13769"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M204793200"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2005.02.064"}],"container-title":["Acta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Faos.14079","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/aos.14079","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/aos.14079","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/aos.14079","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,10]],"date-time":"2023-09-10T07:21:20Z","timestamp":1694330480000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/aos.14079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,25]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["10.1111\/aos.14079"],"URL":"https:\/\/doi.org\/10.1111\/aos.14079","archive":["Portico"],"relation":{},"ISSN":["1755-375X","1755-3768"],"issn-type":[{"value":"1755-375X","type":"print"},{"value":"1755-3768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,25]]},"assertion":[{"value":"2018-09-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}